“…13 Methionine homozygosity at residue 129, as seen in the current case, has been demonstrated in 78% of cases of CJD E200K reported in Libyan Jews. [21][22][23] Further studies are needed to understand the molecular basis underlying the phenotypic variability among patients carrying the PRNP E200K mutation, particularly in those with insomnia. The clinical symptoms include peripheral neuropathy, pruri-tus, insomnia, protracted dementia, or both for several years.…”